scispace - formally typeset
D

Donna K. Arnett

Researcher at University of Kentucky

Publications -  36
Citations -  1254

Donna K. Arnett is an academic researcher from University of Kentucky. The author has contributed to research in topics: DNA methylation & Epigenetics. The author has an hindex of 15, co-authored 36 publications receiving 1020 citations. Previous affiliations of Donna K. Arnett include University of Alabama at Birmingham & University of South Florida.

Papers
More filters
Journal ArticleDOI

A DNA methylation biomarker of alcohol consumption.

Chunyu Liu, +74 more
- 01 Feb 2018 - 
TL;DR: An epigenome-wide association study of methylation of cytosine-phosphate-guanine dinucleotide (CpG) sites in relation to alcohol intake identified a robust alcohol-related DNA methylation signature and shown the potential utility ofDNA methylation as a clinically useful diagnostic test to detect current heavy alcohol consumption.
Journal ArticleDOI

Delayed Hospital Arrival for Acute Stroke: The Minnesota Stroke Survey

TL;DR: By using medical record review, factors that influence the time from stroke onset to patient arrival at metropolitan Minneapolis-St.

Replication of a Gene-Diet Interaction in 3 Independent Populations

TL;DR: In this paper, the authors analyzed gene-diet interactions between the APOA2 �265TC polymorphism and saturated fat intake on BMI and obesity in 3462 individuals from three populations in the United States: the Framingham Offspring Study (1454 whites), the Genetics of Lipid Lowering Drugs and Diet Network Study (1078 whites), and Boston- Puerto Rican Centers on Population Health and Health Disparities Study (930 Hispanics of Caribbean origin).
Journal ArticleDOI

Pharmacogenetics of antihypertensive treatment

TL;DR: To date, more than forty studies have investigated associations between genetic polymorphisms and response to antihypertensive drugs, andRenin-angiotensin-aldosterone system genes have been the most widely studied, with the angiotsin-converting enzyme I/D variant being typed in about one-half of all hypertension pharmacogenetic studies.